MedTrace Logo

Assessment of the Uro-C Cystoscope for Use in Diagnostic Cystoscopy Procedures

NCT03331705 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2017-11-06

No results posted yet for this study

Summary

This is a prospective, multicenter, single-arm, open-label clinical usability study in subjects who are candidates for office diagnostic cystoscopy. The primary objective of this initial device assessment is to evaluate the performance of a new cystoscope for direct visualization of the urethra and bladder.

Conditions

  • Bladder Tumor

Interventions

DEVICE

Uro-C (Use of new cystoscope)

Diagnostic cystoscopic procedure of the urethra and bladder

Sponsors & Collaborators

  • UroSee Corporation

    lead INDUSTRY

Principal Investigators

  • Bela Denes, MD · UroSee Corporation

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-05
Primary Completion
2018-07-05
Completion
2018-09-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03331705 on ClinicalTrials.gov